Study ID | Number of PFD + NAC/PFD Patients | Age (years) (PFD + NAC/PFD) | Country/Study Area | Study Type | Daily Dosage of PFD + NAC [mg/d] | Daily Dosage of PFD [mg/d] | Outcome Parameters |
---|---|---|---|---|---|---|---|
Bonella 2013 [8] | 6/16 | 71.3 ± 7.50/70.5 ± 6.4 | Germany | Cohort | 1200–1800 + 1800 | 1200–1800 | 1, 2, 3, 4, 5, 6 |
Oltmanns 2014 [20] | 11/45 | 68 ± 6.6/68 ± 7.9 | Germany | Cohort | 2400 + 1800 | 2400 | 1, 4, 5, 6 |
Mao 2018 [13] | 35/33 | 59.8 ± 13.4/58.2 ± 9.0 | China | Cohort | 1800 + 600 | 1800 | 1, 2, 3 |
Ma 2018 [12] | 15/15 | 62.1 ± 6.6/64.9 ± 4.3 | China | Cohort | 1800 + 1200 | 1800 | 1, 2, 3, 5, 6 |
Sakamoto 2014 [Inhaled] [14] | 17/10 | 73.5/75.0a | Japan | CC | 1800 + 704.8 | 1800 | 1, 2, 3, 4, 5 |
Behr 2016 [11] | 60/62 | 66.7/67.5a | Europe | RCT | 1602–2403 + 1800 | 1602–2403 | 1, 2, 3, 4, 5, 6 |